Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy

Table 1 Comparison of general data in each group

	TACE group (n = 119)	TACE + TARE group (n = 99)	χ2	P value
Gender			0.512	0.604
Male	63	48
Female	56	51
Age (yr), mean ± SD	56.78 ± 5.68	55.89 ± 5.45	1.173	0.242
Child-Pagh liver function rating			0.463	0.765
Grade A	36	32
Grade B	60	42
Grade C	23	25
Tumor diameter			0.862	0.755
< 5 cm	48	42
< 5 cm	71	57

TACE: Transarterial chemoembolization; TARE: Transarterial radioembolization.